https://*********.com.au/incannex-healthcare-study-lead-drug-ihl-675a-anti-inflammatory-capabilities/
Excellent article about our success in treating lung conditions, asthma, chronic inflammatory lung disease and bronchitis.
.Are they now applying for FDA approval as these were successful trials from what I read .. the next step would be approval then producing the treatments.
- Forums
- ASX - By Stock
- IHL
- Ann: Update on Nasdaq Listing
Ann: Update on Nasdaq Listing, page-149
-
- There are more pages in this discussion • 603 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)